Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies
Clinical trial NCT04933721 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT04933721
- Sponsor
- BioCryst Pharmaceuticals
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-23
- Primary completion
- 2031-08-01
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.